Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies
Anti-tumor necrosis factor α: originators <i>versus</i> biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies
| Reumatismo
© PAGEPress 2008-2023 • PAGEPress® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy
留言 (0)